Recall Record

Monroe, NC, United States

Greiner Bio-One North America, Inc. recalls

12 recalls recorded since 2018, most recently on 19 August 2025. 4 are listed as ongoing. Status and classification are as published by the FDA.

Recalls12
Ongoing (FDA)4
Terminated or completed8
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
19 August 2025
Reason
Some of the Vacuette¿ CAT Serum Separator Clot Activator tubes were manufactured without gel separator, which could yield erroneous assay results and require the patient to return to the lab for recollection or repeat testing. This may result in delayed diagnosis, cause a delay in clinical decision-making or treatment and in some rare cases, yield incorrect results from less stable parameters.
Distribution
U.S.: AL, AR, CA, CO, CT, FL, GA, IA, IL, IN, KS, LA, MA, MD, ME, MI, MO, MS, NJ, NY, OH, OK, PA, TN, TX, UT, VA and WY. O.U.S.: None
Initiated
Voluntary: Firm initiated
Recall number
Z-0571-2026

Ongoing Class II Medical devices

Recall started
8 August 2025
Reason
Blood collection tubes were manufactured with the label applied too high on the tube, which shifted the printed fill level mark upward, which could result in unnecessary sample rejection and repeat collections.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0408-2026

Ongoing Class II Medical devices

Recall started
14 May 2024
Reason
The firm received reports that some blood collection tubes have experienced issues with clotting and poor separation due to missing additive. The failure of the device would likely require sample recollection which could result in a delay of treatment.
Distribution
Nationwide Distribution to states of: AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WV and WY.
Initiated
Voluntary: Firm initiated
Recall number
Z-2375-2024

Ongoing Class II Medical devices

Recall started
12 December 2023
Reason
Tubes have missing additive/anticoagulant resulting in clotting in most cases. A completely clotted sample would lead to no results being reported, which could lead to a delay in treatment or diagnosis. An erroneous glucose or lactose result from a partially clotted sample could lead to inappropriate treatment.
Distribution
US Nationwide distribution in the states of CT, FL, IA, IL, MO, NC, NY, PA, TN, and VA.
Initiated
Voluntary: Firm initiated
Recall number
Z-0733-2024

Completed Class II Medical devices

Recall started
31 March 2023
Reason
Some of the tubes may be incorrectly labeled.
Distribution
US Nationwide distribution in the states of WI and GA.
Initiated
Voluntary: Firm initiated
Recall number
Z-1583-2023

Terminated Class II Medical devices

Recall started
9 December 2021
Terminated
10 October 2023
Reason
Some of the blood collection tubes show clotting due to variation of Lithium Heparin.
Distribution
Distribution was made to FL, IL, MO, NC, NM, NY, PA, TN, TX, and VA. There was no foreign/military/government distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0502-2022

Terminated Class II Medical devices

Recall started
20 August 2021
Terminated
4 October 2023
Reason
Complaint of tubes clotting due to variation of anticoagulant and/or tubes have low vacuum.
Distribution
US Nationwide distribution in the states of AL, AZ, CA, CT, FL, GA, IL, IN, KY, LA, MD, ME, MO, MT, NC, NE, NM, NV, NY, OH, OR, PA, TX, VA, WA and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall number
Z-2507-2021

Terminated Class II Medical devices

Recall started
13 August 2021
Terminated
16 August 2023
Reason
Blood collection tubes may experience a clotting issue.
Distribution
Distribution was made to AL, AZ, CO, CT, FL, IL, MA, MD, MI, MO, NC, NM, PA, TX, and VA. Foreign distribution was made to Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-2485-2021

Terminated Class II Medical devices

Recall started
29 March 2021
Terminated
10 October 2023
Reason
VACUETTE¿ Blood Collection tube 9NC Coagulation sodium citrate 3.2% may show insufficient draw volume of the tubes, which could produce erroneous results for prothrombin time, activated partial thromboplastin time, and fibrinogen assays.
Distribution
US Nationwide distribution in the states of KY, TX, LA, OH, AR, IL, SC, PA, FL, NC, AZ, CA, MI, NE, KS, MI, MO, NY, and NJ.
Initiated
Voluntary: Firm initiated
Recall number
Z-1534-2021

Terminated Class II Medical devices

Recall started
28 August 2020
Terminated
17 June 2021
Reason
Blood collection tubes experienced an issue with separation and clotting
Distribution
US Nationwide distribution including in the states of IL, PA, VA, MO, NY.
Initiated
Voluntary: Firm initiated
Recall number
Z-3027-2020

Terminated Class II Medical devices

Recall started
12 March 2020
Terminated
31 August 2022
Reason
Concerned lot of VACETTE 2mL 9NC Coagulation Tubes were shown to have inconsistent amounts of the 2.3% sodium citrate.
Distribution
US nationwide distribution in the states of: NJ, IN, TN, MI, NC, WA, KS, CA, LA, IL, MD, NY, OH, TX, GA, KY, PA, CO, MA, PR, FL, AR, OK and NE.
Initiated
Voluntary: Firm initiated
Recall number
Z-1714-2020

Terminated Class II Medical devices

Recall started
25 November 2019
Terminated
5 October 2020
Reason
The Vacuette 3.5mL Serup Sep Clot Activator Tubes may have been damaged at the cap sealing area. This may lead to a vacuum loss and tubes not filling up to the proper volume.
Distribution
Nationwide distribution in the states of IL, MO, AZ, NC. PA, UT, NY, ME, PR, VA, PA
Initiated
Voluntary: Firm initiated
Recall number
Z-0818-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.